Understand the clinical journey for patients with Hidradenitis Suppurativa
Challenge
As objective disease severity scales (IHD4, HISCR) are not often collected in real-world clinical practice, longitudinal therapeutic escalation can serve as a good surrogate for disease severity.
Solution
Leverage OM1 linked, deep clinical and claims data to illustrate the longitudinal clinical treatment progression and associated outcomes.
*Counts through Q2 2022
HS patients with diagnosis, deep clinical data including notes from a dermatologist
HS patients with Hurley Stage